Materials and methods
All procedures were conducted in accordance with the National Institute of Health's Guide for the Care and Use of Animals and were approved by the local ethical committee. Twenty male Sprague Dawley rats (mean age: 6 months; range: 5-6 months), each weighing 300 grams, were used. The rats were housed in polycarbonate cages and fed with standard food and water. The rats were randomized into two groups; a spinal fusion group (SF; n=10) or a spinal fusion and oral simvastatin administered group (SFS; n=10). Both groups were fed chocolate for 10 days before the operation. In the SFS group, simvastatin was crushed and mixed with the chocolate to be administered orally at a dose of 120 mg/kg/day (Zocor; Merck, NJ, USA) for seven days preoperatively and continued for 12 weeks postoperatively. An equal amount of chocolate was given to the rats in the SF group. The rats were operated on using the technique described by Dimar. [7] Animals were anesthetized with a 0.45 cc intraperitoneal injection of a solution with a ratio of 60 mg/kg ketamine and 6 mg/kg xylazine. Intramuscular Penicillin G (100,000 U) was used as an infection prophylaxis before the operation. Next, the animals were affixed to a small operating table and shaved and the operation side was sterilized with a 10% povidone iodine solution.
To harvest a bone graft from the tail, the tail was amputated and all soft tissue was removed from the bone using forceps, rongeurs and scalpels. Five vertebrae were separated from the intervertebral discs and all periosteum was removed (Fig. 1) . The bone was morselized with rongeurs and weighed to create a homogenous distribution of the grafts between the groups. The average bone graft was 0.30 g (range: 0.25-0.32 g). A dorsal longitudinal incision was made from L3 through the sacral midline for the posterior spinal fusion procedure. The subcutaneous tissue was sharply dissected and the paravertebral muscles were detached and retracted laterally to the facet joints with automatic retractors. After the meticulous removal of all the posterior spinal soft tissues, decortication of the dorsal surfaces of transverse processes and facet joints was performed with an electrical high-speed burr (Core Ref 5400-50; Stryker, MI, USA). A hole was created in the spinous process of L4, L5 and L6 (representing two level fusion), and a stainless cerclage wire was passed in a figure-ofeight fashion to enhance stabilization. After stabilization, the autogenous bone graft harvested from the tails was placed along the posterior lamina and transverse processes (Fig. 2) . The paraspinal muscles were closed with a running suture and the incision was closed with metal clips.
All animals survived for 12 weeks and at the end of the 12 week period they were killed using an intra-abdominal injection of pentobarbital (100 mg/kg body weight). All soft tissue and muscles were dissected from the spinal segment L2 through the sacrum. The lumbar vertebrae and the sacrum were then enblock resected. All cerclage wires were removed and the fusion sites were assessed by three examiners using a manual palpation method for the signs of pseudoarthrosis [7] ( Table 1) . Micro-motions in either plane (coronal and sagittal) were assessed for each level (L4-L5 and L5-L6). Radiographies of all animals were taken and an assessment of fusion mass was performed according to Lenke et al. [8] ( Table 1; Figs. 3 and 4). A biomechanical threepoint bending test was performed using a mechanical testing device (Hounsfield H50KM; Hounsfield Test Equipment Ltd., Surrey, England). The specimens were placed on the machine with the dorsal sides facing towards the tip of the force applier.
Force was applied to the middle of the fused segment at a constant rate of 10 mm/minute until failure occurred. The force at the time of the failure was recorded in Newton units.
Histological examination was made in both groups. After removal of their soft tissue, the spinal segments from L2 to the sacrum were fixed in a solution of 10% formalin, decalcified and stained with a standard hematoxylin eosin stain. Next, examination was made under standard light microscopy. Histological examination was made as described in the study by Huddlestone et al. [9] (Table  1) , on four fields per specimen (each specimen had two levels, and each level two fields; right and left). The scores of the four fields were averaged.
Statistical analysis
A Kolmogorov-Smirnov test was used to determine the distribution of the two groups. Two independent t-tests were used to compare the biomechanical threepoint bending forces and histopathological scores of group SF and group SFS. Significance level was set at p<0.05 and calculations were performed using SPSS software (SPSS Inc., IL, USA).
Results
Manuel palpation revealed two moderate fusions in 20 levels (90%) in the SF group, whereas the treatment group revealed no signs of pseudoarthrosis in 20 levels. An average three-point bending force causing failure of fusion revealed 148.80±39.403 Newtons and 123.80±28.479 Newtons in the SFS and SF groups, respectively (p>0.05) ( Table 2 ). Histological exami- Grade of fusion Manual palpation (Dimar et al. [7] )
Solid
No micro-motion in anteroposterior and lateral planes Moderate Micro-motion in one plane
Pseudoarthrosis Unrestricted motion in either plane
Grade of fusion Histological examination (Huddlestone et al. [9] ) (Figs. 3 and 4) .
Discussion
Posterior spinal fusion is commonly used for spinal operations for spondylolisthesis, scoliosis, kyphosis, degenerative spinal disorders and tumors. [6] To prevent pseudoarthrosis, new substitutes have been used in clinical and experimental studies, such as heterologous demineralized bone matrix, bone morphogenetic protein-7, and osteogenic protein-1. [10] [11] [12] [13] BMPs are important regulators of the bone in the healing of fractures. [5] It has been reported that statins -especially lovastatin and simvastatin-stimulate bone formation by inducing the expression of BMP-2 and that orally administered drugs increase cancellous bone volume. [4] Furthermore, angiogenesis is essential for bone formation. [5] Hydrophobic statins stimulate vascular endothelial growth factor expression in osteoblasts, which in turn promote differentiation. [14] Another effect of simvastatin on bone formation is the inhibition of inflammation. [15] Statins inhibit the HMG-CoA reductase enzyme which is key in the formation of cholesterol and other pathways, including the formation of farnesylpyrophosphate (which is necessary for activation of osteoclasts). [16] Beneficial effects of HMG-CoA reductase inhibitors on cardiac events are mainly due to their hypocholesterolemic effects. [17, 18] Minimal side effects of statins have been reported. [3] Another statin, called cerivastatin, given at a high dose (1.0 mg/kg/day) induced bone union of allograft to host bone in a rat model in one study. This effect was attributed to more bone growth due to the increase of BMP-2 and vascular endothelial growth factor. [19] Rats are good candidates for spinal fusion models. [10, 20] We used a drug delivery model developed by Huang-Brown and Guhad [21] which is reported to be an effective, consistent, reliable method of oral drug delivery to a large group of rats for a long period of time. The meta-analysis study by Douglas et al. suggests that statins cause significant reduction in hip and non-spine fractures. [22] The effect of the systemic and local administration of simvastatin on bone healing has been investi- Table 2 . Biomechanical and histological test results of the two groups. gated in several studies. [19, [23] [24] [25] [26] [27] [28] [29] [30] Wong and Rabie created 15 defects in the parietal bone of rabbits; five of them were grafted with simvastatin collagen grafts, five were grafted with collagen alone, and the last group were left empty. [24] The simvastatin collagen graft group revealed 308% more new bone formation than collagen grafts. Wong and Rabie concluded that statin collagen grafts can be used with other bone grafting materials (such as autogenous bone grafts) to exert their osteoinductive effects on larger defects. [24] Mundy et al. suggested that a subcutaneous injection of simvastatin causes a 50% increase in new bone formation in rat calvaria at 21 days; this observation is comparable to that seen with fibroblast growth factor. [25] Wong and Rabie found that a statin graft applied to the defect in a skull of a rabbit induced bone formation by day five; by the 14th day, an abundance of bone formation was detected. [26] Stein et al. reported that locally applied simvastatin in methylcellulose gel leads to a 45% increase in bone area in the mandible. [29] In a study by Ma et al., the effect of oral simvastatin on bone formation and ceramic resorption in a peri-implant defect model was investigated and reported to be ineffective in repairing defects; this was because the drug was severely eliminated by the liver which led to poor bioavailability. [30] In another study by Skoglund et al. 40 mice were given 120 mg/kg simvastatin orally per day; this resulted in a 53% bigger transverse area, a 150% increase in energy uptake at 14 days in a femur fracture model. It was also observed that a 63% greater force was required to break the bone. [23] This is a very high dose for animals but it is necessary for the bioavailability of the drug in the bone. However, such high doses cannot be used in clinical practice.
Patil et al. investigated the effect of orally administered simvastatin (20 mg/day) on fracture healing of the distal radius in humans in a prospective, double-blind, randomized controlled trial. [28] They randomized 62 patients into two placebo and drug groups. Thirty-one patients in the drug group did not show significant differences with respect to fracture healing at the end of 12 weeks. They attributed this result to a high clearance of simvastatin in the liver leading to inadequate levels of the drug at the bone tissue level. Thus, in the present study, we used high doses of simvastatin to overcome the clearance of the drug in the liver as did Skoglund et al. in their study. Yee et al. reported the results of orally administered simvastatin on a spinal posterolateral fusion model in rabbits and stated that it has no beneficial effect on spinal fusion. [31] However, the drug dose used in the study (6.5 mg/kg/day) was very low, and the drug did not show a beneficial effect on the spine due to its clearance in the liver. Because of this observation, we used very high doses (120 mg/kg/day) to overcome this problem.
Although an average three-point bending force causing failure of fusion was measured at 148.80 ±39.403 Newtons in the SFS group and 123.80 ±28.479 Newtons in the SF group, the difference was not statistically significant in the present study (p>0.05). However, with manual examination our research revealed moderate fusion in two levels in the SF group, while there was no pseudoarthrosis in the SFS group. Biomechanical tests may not always be correlated with the manual examination method and radiographies. Some reports in the literature have stated that manual examination is the gold standard for assessing spinal fusion. [7, 10, 20, 32] Our results are consistent with these reports. Histopathological results are correlated with radiographies and manual palpation tests in the current study. The two specimens (two levels) where moderate fusion was detected by manual palpation in the SF group revealed a Grade C fusion on radiography and Grades 3 and 5 on histological examination.
In conclusion, we suggest that simvastatin can promote spinal fusion. If the bioavailability of simvastatin in the bone can be adjusted by lowering its clearance in the liver it can be used as an adjunct to spinal fusion procedures in elderly populations with high cholesterol levels.
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